Anlotinib plus whole-brain radiotherapy for NSCLC brain metastases: a prospective, non-randomized, single-center cohort study

Abstract This study focuses on the vessel normalization window of anlotinib to preliminarily explore the optimal intervention timing for combining anlotinib with whole brain radiotherapy (WBRT) in treating brain metastases from non-small cell lung cancer (NSCLC). We aimed to explore the feasibility...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Shuai Li, Zongying Pan, Ruilin Chen, Shumei Xu, Yajie Wang, Guilin Zeng, Yamao Li, Lang He
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2026-05-01
Цуврал:	Scientific Reports
Нөхцлүүд:	Anlotinib Whole brain radiotherapy Non-small cell lung cancer Brain metastases Anti-angiogenesis
Онлайн хандалт:	https://doi.org/10.1038/s41598-026-52632-2
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!